CALYXTPAR Stock price

Equities

CLXT

US13173L2060

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq 23:00:00 04/02/2024 GMT 5-day change 1st Jan Change
17.59 USD 0.00% Intraday chart for CALYXTPAR +2.93% -10.44%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2023 * 1.13M 88.7M Sales 2024 * 2.28M 180M Capitalization 340M 26.84B
Net income 2023 * -83M -6.54B Net income 2024 * -78M -6.15B EV / Sales 2023 * 303 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 149 x
P/E ratio 2023 *
-2.38 x
P/E ratio 2024 *
-6.44 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 80%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 71 -
Director of Finance/CFO 67 -
President 61 -
Members of the board TitleAgeSince
Chief Executive Officer 71 -
Director/Board Member 81 -
Director/Board Member 76 -
More insiders
Cibus, Inc. is an agricultural technology company. The Company is engaged in developing and licensing plant traits to seed companies for royalties on seed sales. The Company is involved in gene-edited trait development, where plant traits (or specific genetic characteristics) that are indistinguishable from traits developed using traditional breeding are created using gene editing. Its patented RTDS technology platform includes the Trait Machine, which is a semi-automated stand-alone trait production facility. The Company’s Trait Machine materially changes the speed, breadth, and scale of trait development. It is focused on the development of productivity traits and sustainable ingredients. The Company focuses on developing traits for addressing the sustainability challenges presented by climate change, disease, and pests.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
17.97 USD
Average target price
22 USD
Spread / Average Target
+22.43%
Consensus
  1. Stock
  2. Equities
  3. Stock CALYXTPAR - Nasdaq
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW